| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | United States | 5 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Canada | 3 | |
| #5 | Mexico | 3 | |
| #6 | WIPO (World Intellectual Property Organization) | 3 | |
| #7 | China | 2 | |
| #8 | Israel | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Brazil | 1 | |
| #11 | Hungary | 1 | |
| #12 | Japan | 1 | |
| #13 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Guedat Philippe | 26 |
| #2 | Miniou Pierre | 5 |
| #3 | Philippe Guedat | 5 |
| #4 | Anne Bertolotti | 2 |
| #5 | Bertolotti Anne | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017021216A1 | Method of treating cancer with a combination of benzylideneguanidine derivatives and chemotherapeutic agent. | |
| US2017151196A1 | Therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies | |
| CA2951186A1 | O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins |